Transaction in Own Shares

Summary by AI ^BETAClose X

Fevertree Drinks plc has announced the purchase of 77,666 ordinary shares between March 23rd and March 27th, 2026, as part of its share buyback program. The volume-weighted average purchase price across these transactions was approximately 784.84 pence per share, with individual prices ranging from 716.00 pence to 822.00 pence. The company intends to cancel these repurchased shares.

Disclaimer*

Fevertree Drinks PLC

31 March 2026

31^st March 2026

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5^th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 23^rd March 2026 to 27^th March 2026.

Date	Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (p)	Highest price per share (p)
23 March 2026	XLON	748.1812	15,980	721.0000	765.0000
24 March 2026	XLON	800.7069	16,000	716.0000	822.0000
25 March 2026	XLON	797.0201	14,787	781.0000	817.0000
26 March 2026	XLON	779.4456	15,919	767.0000	790.0000
27 March 2026	XLON	784.6059	14,970	777.0000	792.0000

The Company intends to cancel the purchased shares.

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/6457Y_1-2026-3-30.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

For further information please contact:

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END